Vitamin C

The VerdictMODERATE CONVICTIONVerdict Score 78Worth-It: Low ROI (52/100)

Vitamin C is essential, but your blood saturates at 200mg — mega-dosing is expensive urine that may blunt your gym gains.

Check your vitamin C supplement bottle right now. If it says 1000mg, you're taking the wrong dose — and if you train, it may be actively slowing your progress. Switch to 200–500mg/day. That's where your blood saturates; everything above is mostly urine.

The evidence is clear: blood plasma saturates at 200–400mg/day — a 1000mg tablet provides no more circulating vitamin C than a 250mg one.
What most people get wrong: high-dose vitamin C (1000mg+) actively blunts resistance and endurance training adaptations — multiple RCTs confirm it suppresses the exact cellular signals (PGC-1α, p70S6K) that make you stronger.
Start here: 200–500mg/day of standard ascorbic acid, divided if over 200mg, not post-workout. That's it.

Think of vitamin C like filling a glass of water. Your bloodstream is the glass — it holds about 200–400mg worth before it's full. Pour in 1000mg and the extra spills straight out in your urine. Worse: those "spilled" antioxidants don't just do nothing. In muscle tissue they mop up the oxidative stress signals your training needs to build you stronger.

That's the general answer. Your stack is different.

Check your whole stack

The Protocol

Dosing by Population

Population	Dose	Timing	Form	Source
General adult	200–500mg/day	With meals; split if >200mg	Ascorbic acid	Levine 1996, NIH ODS
Smokers	200–400mg/day	With meals	Ascorbic acid	NIH ODS 2021
Athletes (resistance/endurance)	≤200mg/day; cap at 500mg	NOT post-workout	Ascorbic acid	Paulsen 2014; Bjørnsen 2016
Wound healing / surgical	200–500mg/day	With meals, continue 4–8 weeks post-op	Ascorbic acid	Hujoel 2021
Extreme endurance athletes (cold prevention)	200–500mg/day	Daily during competition/training block	Ascorbic acid	Hemilä & Chalker 2013
IV — critical care (clinical only)	50 mg/kg every 6 hours, 96hrs	Continuous IV	IV Ascorbate	CITRIS-ALI 2019

Forms Comparison

Ascorbic Acid

~100% at ≤200mg

General use, best value

£3–8/month

Sodium Ascorbate

Equivalent absorption

GI-sensitive stomachs

£5–10/month

Ester-C

Minor leukocyte advantage (debated)

Buffered form seekers

£10–18/month

Liposomal

~1.3–1.8× AUC vs standard

High-dose oral when IV unavailable

£20–40/month

IV Ascorbate

13,400 µmol/L achievable

Clinical setting only

Clinical pricing

Absorption Notes

Divide doses if taking >200mg — splitting 500mg into morning/evening provides better sustained plasma levels than a single 500mg dose.

Vitamin C dramatically enhances non-heme (plant-based) iron absorption — beneficial if iron-deficient, but dangerous if you have hereditary hemochromatosis.

Liposomal forms improve AUC by 30–70% vs standard at high doses but do NOT achieve IV-equivalent plasma concentrations. The "IV-equivalent" claim is marketing, not pharmacokinetics.

Safety

Safety & Interactions

⚠ Athletes — Exercise Adaptation Blunting

≥1000mg/day prematurely quenches exercise-induced ROS, blunting PGC-1α (mitochondrial biogenesis) and p70S6K (muscle protein synthesis) signalling. Multiple RCTs confirm 50–64% blunted FFM gains vs placebo. Severity: Moderate-High. Action: Cap at 200–500mg/day; avoid post-workout timing.

⚠ Kidney Stones — Oxalate Risk

≥1000mg/day significantly increases urinary oxalate excretion (~20–33%), doubling kidney stone risk in men. Severity: Moderate (High in prior stone history). Action: Stay below 500mg/day; high fluid intake if supplementing.

⚠ G6PD Deficiency — Absolute Contraindication (IV)

In G6PD-deficient patients, high-dose IV vitamin C acts as a pro-oxidant, triggering severe acute hemolysis and acute kidney injury. Severity: Severe. Action: G6PD screening required before any IV protocol.

⚠ Hemochromatosis

Vitamin C markedly enhances non-heme iron absorption. In hereditary hemochromatosis, this accelerates iron overload. Severity: Moderate. Action: Avoid supplemental vitamin C.

⚠ Chemotherapy / Radiation

Antioxidants theoretically protect cancer cells from intended oxidative damage. Severity: Moderate-Severe. Action: Only under oncologist supervision — do not self-initiate.

ℹ Iron Absorption Enhancement

Beneficial for iron-deficient individuals taking non-heme iron. Moderate interaction. Action: Use intentionally if iron-deficient; avoid if hemochromatosis.

ℹ Statins + Niacin

Antioxidant combinations may reduce lipid-lowering efficacy. Severity: Moderate. Action: Flag to prescribing physician if taking high-dose vitamin C with statins.

Tolerable Upper Intake Level (UL): 2,000mg/day (US Food and Nutrition Board). Main concerns: GI osmotic diarrhea and oxalate excretion above this threshold. No systemic toxicity in healthy adults at oral doses.

Conviction

MODERATE Conviction

Deficiency prevention and wound healing earn HIGH conviction. Cold duration reduction is real but modest (8–14%). Exercise blunting is HIGH conviction but a harm signal, not an efficacy claim. Cold prevention for the general population is LOW.

Deficiency / Scurvy Prevention

HIGH

Wound Healing / Surgical

HIGH

Cold Duration Reduction

MODERATE

Cold Prevention — Extreme Athletes

MODERATE

Exercise Blunting at ≥1000mg

HIGH (harm)

Cold Prevention — General Population

LOW

Cardiovascular Protection

LOW

Cancer Prevention (oral)

LOW

IV Sepsis / Critical Illness

LOW–MOD

What would change this?

For exercise blunting: A long-term RCT (6-month, MRI-assessed, N>200) testing 200–400mg vitamin C vs placebo in recreational athletes to establish the exact inflection point where adaptation blunting begins. For sepsis: A phase III mortality-powered RCT (N>1000) stratifying by baseline serum ascorbate levels with mortality as primary endpoint.

Sources

Key References

Hemilä H & Chalker E (2013). Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. N=11,306 across 29 trials. 8% duration reduction in adults; 50% incidence reduction in extreme athletes under physical stress only.
Levine M et al. (1996). Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS. N=7. Plasma saturation at 200–400mg/day; renal excretion dominates above 1000mg.
Fowler AA et al. (2019) CITRIS-ALI. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe ARDS. JAMA. N=167. Primary SOFA endpoint: not met (p=0.86). Secondary 28-day mortality: 29.8% vs 46.3% (p=0.03).
Paulsen G et al. (2014). Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial. J Physiol. N=54+32. Blunted mitochondrial protein expression and p70S6K hypertrophy signalling at 1000mg Vit C + 235mg Vit E.
Bjørnsen T et al. (2016). Vitamin C and E supplementation blunts increases in total lean body mass in elderly men after strength training. Scand J Med Sci Sports. N=34. Rectus femoris: 16.2% vs 10.9% gain (p<0.05) favouring placebo.
Hujoel PP et al. (2021). Revisiting the evidence of minimum dietary vitamin C needs: what we can learn from a depletion study conducted in the 1940s. Am J Clin Nutr. N=20. 95mg/day required for optimal wound scar tensile strength in 97.5% of population.
AREDS Research Group (2001). A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration. Arch Ophthalmol. N=4,757. 25% risk reduction for AMD progression in Category 3/4 patients with AREDS multi-ingredient formula.

Action ROI

Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.

Action ROI score

52/100 Low ROI Trust grade B

No for most - it does not prevent colds and food covers it. Genuinely worth it only for deficient, surgical, smoker, or extreme-athlete cases at 200-500mg.

Time

Low

Money

Low

Effort

Low

Risk

Medium

Why this score

For the headline reason people buy it, immune and cold prevention, it does not work: Cochrane (Hemila and Chalker 2013, N=11,306) found no prevention in the general population (RR 0.97), only an 8% cut in cold duration in adults. Verdict 78, B-grade.
It is cheap ($3-8/month for standard ascorbic acid), but food-first makes it nearly redundant: one orange plus one bell pepper is about 190mg, and plasma fully saturates at 200-400mg/day.
Taking it is trivial, one capsule daily with a meal, but that low effort buys very little for a well-nourished person.
Real downside at the dose the market actually sells (1,000mg tablets): mega-dosing blunts resistance and endurance training adaptations (Paulsen 2014, Bjornsen 2016) and roughly doubles kidney-stone risk in men.
The genuine value is narrow: scurvy and deficiency correction plus wound healing at 200mg (STRONG), smokers, and a 50% cold-incidence drop in extreme endurance athletes during hard training blocks.

Why it didn’t score higher

The reason it sits on most shelves, cold prevention and immune boosting, is the one thing the evidence says it does not do for the general population.
Plasma saturates at 200-400mg, so the common 1,000mg dose is mostly expensive urine, and at that dose it actively harms trainees and raises kidney-stone risk.
Food-first (fruit and vegetables) covers the need for most well-nourished adults, leaving little marginal benefit to buy.

Best for

People with dietary deficiency (processed-food diets, institutionalized elderly)
Surgical and wound-healing patients (200-500mg/day perioperative)
Smokers (higher metabolic turnover, 200-400mg/day baseline)
Extreme endurance athletes during high-stress training or competition blocks (50% cold-incidence reduction)

Lower ROI if

You already eat adequate fruit and vegetables
You train for size or endurance and dose at 1,000mg or more (net-negative for adaptation)
You are a man with a history of calcium-oxalate kidney stones
You are buying liposomal vitamin C for 'IV-equivalent' immunity, a claim that does not hold at physiological doses

Minimum effective dose

200-500mg/day of standard ascorbic acid, divided if taking more than 200mg at once. Plasma saturates at 200-400mg/day, so there is no reason to exceed it. Active athletes should cap at 200mg/day and avoid dosing immediately post-workout.

Track this

Cold duration if you use it acutely (expect only a modest ~8% shortening, not prevention)
No useful acute marker for general immune use, the effect is largely silent